# Zachary S. Wallace

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zachary-s-wallace/

## Facts

| Field | Value |
| --- | --- |
| Citations | 15,759 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 57 |
| i10-index | 149 |
| Last Known Institution | Amgen (United States) |
| OpenAlex ID | https://openalex.org/A5018239396 |
| ORCID iD | 0000-0003-4708-7038 |
| Works | 289 |

## Researcher papers

- [Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry](https://scholariq.org/papers/characteristics-associated-with-hospitalisation-for-covid-19-in-people-with/)
- [International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease](https://scholariq.org/papers/international-consensus-guidance-statement-on-the-management-and-treatment-of/)
- [The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease](https://scholariq.org/papers/the-2019-american-college-of-rheumatology-european-league-against-rheumatism/)
- [Rituximab for IgG4-related disease: a prospective, open-label trial](https://scholariq.org/papers/rituximab-for-igg4-related-disease-a-prospective-open-label-trial/)
- [Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry](https://scholariq.org/papers/factors-associated-with-covid-19-related-death-in-people-with-rheumatic-diseases/)
- [The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Disease](https://scholariq.org/papers/the-2019-american-college-of-rheumatology-european-league-against-rheumatism-2/)
- [IgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five Patients](https://scholariq.org/papers/igg4-related-disease-clinical-and-laboratory-features-in-one-hundred-twenty-five/)
- [Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations](https://scholariq.org/papers/plasmablasts-as-a-biomarker-for-igg4-related-disease-independent-of-serum-igg4/)
- [Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease](https://scholariq.org/papers/clonal-expansion-of-cd4-cytotoxic-t-lymphocytes-in-patients-with-igg4-related/)
- [Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts](https://scholariq.org/papers/clinical-phenotypes-of-igg4-related-disease-an-analysis-of-two-international/)
- [All‐Cause and Cause‐Specific Mortality Trends of End‐Stage Renal Disease Due to Lupus Nephritis From 1995 to 2014](https://scholariq.org/papers/all-cause-and-cause-specific-mortality-trends-of-end-stage-renal-disease-due-to/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [IgG4-Related and Inflammatory Diseases](https://scholariq.org/topics/igg4-related-and-inflammatory-diseases/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Researcher university

- [Amgen (United States)](https://scholariq.org/institutions/amgen-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.